CEACAM5 and familial pancreatic carcinoma: In contrast, CEA and CA19-9, common tumor biomarkers used in diagnosing pancreatic cancer, have sensitivity and specificity for PDAC of 70–90% and 43–91% and 45–60% and 75–99%, respectively [32,33,34].